Bharat Biotech Vaccine
- All
- News
- Videos
-
Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps
HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent
Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the Covid-19 vaccine patent.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
Maharashtra To Buy 2 Lakh Vials Of Covid Vaccine From Bharart Biotech
The Maharashtra government will buy two lakh vials of COVID-19 vaccines from Bharart Biotech amid a rise in cases, an official said on Monday.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
-
Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps
HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent
Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the Covid-19 vaccine patent.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
Maharashtra To Buy 2 Lakh Vials Of Covid Vaccine From Bharart Biotech
The Maharashtra government will buy two lakh vials of COVID-19 vaccines from Bharart Biotech amid a rise in cases, an official said on Monday.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
